Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sample size calculations in thorough QT studies.

Lu Zhang1, Alex Dmitrienko, George Luta

  • 1Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, USA.

Journal of Biopharmaceutical Statistics
|May 13, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lung cancer screening completion rates and neighborhood disadvantage among primary care patients in an integrated delivery network health system: a retrospective data analysis.

BMC primary care·2026
Same author

Using the WHO Health Equity Assessment Toolkit to investigate changes in rural vs urban malnutrition inequality for low- and middle-income countries.

International journal for equity in health·2026
Same author

Patient-reported Psychological and Prostate Cancer-specific Functional Outcomes Among Men With Low-risk Prostate Cancer Two Years After Diagnosis: The PREPARE Prospective Cohort Study.

Urology·2026
Same author

Symmetric alternatives to the ordinary least squares regression.

Nature methods·2025
Same author

On the current and future potential of simulations based on directed acyclic graphs.

Global epidemiology·2025
Same author

Randomized trial of a community-based, culturally tailored intervention: High engagement among Latina breast cancer survivors.

Cancer·2025
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

This study analyzed QTc data to understand variability and developed a sample size framework for thorough QT studies. This framework helps researchers optimize clinical trial design by considering factors like study type and participant demographics.

Area of Science:

  • Pharmacology and Clinical Trials
  • Cardiovascular Safety Assessment
  • Statistical Analysis in Drug Development

Background:

  • The QTc interval is a critical measure of cardiac repolarization, essential for assessing drug-induced cardiovascular safety.
  • Thorough QT studies are mandated by regulatory agencies to evaluate the potential of new drugs to prolong the QTc interval.
  • Accurate estimation of QTc variability is crucial for designing efficient and statistically sound clinical trials.

Purpose of the Study:

  • To analyze QTc data from multiple thorough QT studies to estimate QTc interval variability.
  • To develop a flexible sample size calculation framework for thorough QT studies.
  • To provide researchers with a tool to optimize sample size based on study design and population characteristics.

Main Methods:

Related Experiment Videos

  • Analysis of pooled QTc data from four Eli Lilly conducted thorough QT studies.
  • Estimation of variance components contributing to QTc interval variability (e.g., time-to-time, day-to-day).
  • Development of a sample size calculation framework incorporating study design, ECG recording parameters, and subject demographics.

Main Results:

  • Quantification of QTc interval variability, identifying key sources of variation.
  • Establishment of a novel sample size calculation framework for thorough QT studies.
  • Demonstration of the framework's utility across various common study designs.

Conclusions:

  • The developed framework provides a robust method for sample size determination in thorough QT studies.
  • This approach allows for more precise and efficient clinical trial planning, accounting for critical sources of QTc variability.
  • Optimized sample sizes can lead to more reliable cardiovascular safety assessments and potentially reduce development costs.